. Graphs of fold induction (as luciferase activity) in the MN8CampLuc reporter cell line as elicited by APD's 2-9 with or without pre-differentiation of the cells with galactose. (red columns: data from pre-differentiated cells; Blue columns: data from non predifferentiated cells). Error bars represent standard deviation. The fold induction values are relative to the background from untreated cells and all experiments were performed in duplicate (triplicate for some). Bars for standard deviation are shown and all differences with compounds 2-9 relative to untreated cells were statistically significant (Student's t-test p-values were all <0.01 except for 2.5 μM of 2 in prediff. cells (upper graph, red bar, p-value, 0.025)) except for 2.5 μM of 3 (upper graph, red bar, p-value, 0.60, blue bar, p-value 0.12). Apart from at the two highest concentrations of 17 the difference to untreated cells were not significant for prediff. cells (p-values: 0.16, 0.18, 0.24 and 0,08 for 2.5, 10, 25 and 50 μM, respectively). With non-prediff. cells (blue bars) the differences were however significant (p-values < 0.01) which may suggest that a major reason for the induction with 17 is its ability to differentiate the cells and representative for the extent of induction obtained by only HDAC inhibition.
S 2: Induction vs HDAC inhibition.
The potent HDAC inhibitors Vorinostat (17) and Trichostatin A (18) give considerably lower fold induction than compound 5 ( Figure S2 ) although all known IC50 values for HDAC inhibition shows that compounds 17 and 18 are considerably more powerful HDAC inhibitors (Table S1 ). a The average IC50 values from all reported assays in PubChem (2014-07-08) was used. Assays with any data from specific compounds deviating more than 2 standard deviations from the average, were excluded. b HDAC type not specified in the assay. # Number of assays included in the dataset.
S 3: Induction with compound 19 that has a more flexible non-benzoyl amide linked to the phenylenediamine. S 4: Bacterial count from three recovering rabbits upon administration of a 2mg single dose of pyridin-3-ylmethyl (4-((2-aminophenyl)carbamoyl)benzyl)carbamate (5, Entinostat). Figure S4 . Graph of bacterial count from stool of Shigella infected rabbits after treatment with a single 2mg dose of 5 (average from three rabbits since one of the five was weak and sacrificed and one died in the first night, one rabbit was also not included for day 1 and 2 since colonies were uncountable due to contamination on day three and four). Error bars represent spread of count values for the different rabbits. The reduction in counts from day one to four is not statistically significant (paired t-test p-value, 0.2), partially because not enough rabbits survived or could give countable colonies, but the trend is similar to what was found with the lower doses.
S 5: Immunohistochemical staining of CAP-18 in sections of colon from healthy rabbits and a rabbit model of Shigellosis, at two different magnifications. In Shigella-infected rabbits, epithelial surface was almost devoid of CAP-18 staining and abundant CAP-18-expressing inflammatory cells were seen in the lamina propria. c and f: Reappearance of CAP-18 staining in the surface epithelium and disappearance of CAP-18 expressing cells from the lamina propria in infected rabbits treated with 0.5 mg doses (twice daily for two days) of pyridin-3-ylmethyl (4-((2-aminophenyl)carbamoyl)benzyl)carbamate (5, Entinostat).
